Literature DB >> 10518573

Visualizing the kinetics of tumor-cell clearance in living animals.

T J Sweeney1, V Mailänder, A A Tucker, A B Olomu, W Zhang, Y a Cao, R S Negrin, C H Contag.   

Abstract

Evaluation of potential antineoplastic therapies would be enhanced by noninvasive detection of tumor cells in living animals. Because light is transmitted through mammalian tissues, it was possible to use bioluminescence to monitor (both externally and quantitatively) growth and regression of labeled human cervical carcinoma (HeLa) cells engrafted into immunodeficient mice. The efficacy of both chemotherapy and immunotherapeutic treatment with ex vivo expanded human T cell-derived effector cells was evaluated. In the absence of therapy, animals showed progressive increases in signal intensity over time. Animals treated with cisplatin had marked reductions in tumor signal; 5'-fluorouracil was less effective, and cyclophosphamide was ineffective. Immunotherapy dramatically reduced signals at high effector-to-target cell ratios, and significant decreases were observed with lower ratios. This model system allowed sensitive, quantitative, real-time spatiotemporal analyses of the dynamics of neoplastic cell growth and facilitated rapid optimization of effective treatment regimens.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10518573      PMCID: PMC18409          DOI: 10.1073/pnas.96.21.12044

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  27 in total

1.  Noninvasive assessment of tumor cell proliferation in animal models.

Authors:  M Edinger; T J Sweeney; A A Tucker; A B Olomu; R S Negrin; C H Contag
Journal:  Neoplasia       Date:  1999-10       Impact factor: 5.715

Review 2.  The use of the polymerase chain reaction for the detection of minimal residual malignant disease.

Authors:  R S Negrin; K G Blume
Journal:  Blood       Date:  1991-07-15       Impact factor: 22.113

3.  Isolation and characterization of mutants of firefly luciferase which produce different colors of light.

Authors:  N Kajiyama; E Nakano
Journal:  Protein Eng       Date:  1991-08

4.  Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice.

Authors:  H Takahashi; T Nakada; I Puisieux
Journal:  Science       Date:  1993-03-05       Impact factor: 47.728

5.  Comparative studies of CD3- and CD3+ CD56+ cells: examination of morphology, functions, T cell receptor rearrangement, and pore-forming protein expression.

Authors:  J R Ortaldo; R T Winkler-Pickett; H Yagita; H A Young
Journal:  Cell Immunol       Date:  1991-09       Impact factor: 4.868

6.  A model of human acute lymphoblastic leukemia in immune-deficient SCID mice.

Authors:  S Kamel-Reid; M Letarte; C Sirard; M Doedens; T Grunberger; G Fulop; M H Freedman; R A Phillips; J E Dick
Journal:  Science       Date:  1989-12-22       Impact factor: 47.728

7.  Expansion of Philadelphia chromosome-negative CD3(+)CD56(+) cytotoxic cells from chronic myeloid leukemia patients: in vitro and in vivo efficacy in severe combined immunodeficiency disease mice.

Authors:  C Hoyle; C D Bangs; P Chang; O Kamel; B Mehta; R S Negrin
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

8.  Long-term growth of lymphokine-activated killer (LAK) cells: role of anti-CD3, beta-IL 1, interferon-gamma and -beta.

Authors:  A C Ochoa; G Gromo; B J Alter; P M Sondel; F H Bach
Journal:  J Immunol       Date:  1987-04-15       Impact factor: 5.422

9.  A subset of natural killer cells in peripheral blood displays a mature T cell phenotype.

Authors:  R E Schmidt; C Murray; J F Daley; S F Schlossman; J Ritz
Journal:  J Exp Med       Date:  1986-07-01       Impact factor: 14.307

10.  Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity.

Authors:  I G Schmidt-Wolf; R S Negrin; H P Kiem; K G Blume; I L Weissman
Journal:  J Exp Med       Date:  1991-07-01       Impact factor: 14.307

View more
  94 in total

Review 1.  Use of reporter genes for optical measurements of neoplastic disease in vivo.

Authors:  C H Contag; D Jenkins; P R Contag; R S Negrin
Journal:  Neoplasia       Date:  2000 Jan-Apr       Impact factor: 5.715

2.  Whole-body optical imaging of green fluorescent protein-expressing tumors and metastases.

Authors:  M Yang; E Baranov; P Jiang; F X Sun; X M Li; L Li; S Hasegawa; M Bouvet; M Al-Tuwaijri; T Chishima; H Shimada; A R Moossa; S Penman; R M Hoffman
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-01       Impact factor: 11.205

Review 3.  Molecular-genetic imaging: current and future perspectives.

Authors:  Ronald G Blasberg; Juri Gelovani Tjuvajev
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

4.  Shifting foci of hematopoiesis during reconstitution from single stem cells.

Authors:  Yu-An Cao; Amy J Wagers; Andreas Beilhack; Joan Dusich; Michael H Bachmann; Robert S Negrin; Irving L Weissman; Christopher H Contag
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-19       Impact factor: 11.205

Review 5.  Defining the success of cardiac gene therapy: how can nuclear imaging contribute?

Authors:  Norbert Avril; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2003-01-23       Impact factor: 9.236

Review 6.  Apoptosis-detecting radioligands: current state of the art and future perspectives.

Authors:  Christophe M M Lahorte; Jean-Luc Vanderheyden; Neil Steinmetz; Christophe Van de Wiele; Rudi A Dierckx; Guido Slegers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-12       Impact factor: 9.236

Review 7.  Animal models of bone metastasis.

Authors:  Thomas J Rosol; Sarah H Tannehill-Gregg; Stephanie Corn; Abraham Schneider; Laurie K McCauley
Journal:  Cancer Treat Res       Date:  2004

8.  Ex vivo expanded dendritic cells home to T-cell zones of lymphoid organs and survive in vivo after allogeneic bone marrow transplantation.

Authors:  Christoph H Schimmelpfennig; Stephan Schulz; Caroline Arber; Jeanette Baker; Ingo Tarner; Jacqueline McBride; Christopher H Contag; Robert S Negrin
Journal:  Am J Pathol       Date:  2005-11       Impact factor: 4.307

Review 9.  Molecular optical imaging: applications leading to the development of present day therapeutics.

Authors:  Khalid Shah; Ralph Weissleder
Journal:  NeuroRx       Date:  2005-04

Review 10.  Bioluminescence imaging.

Authors:  Ruxana T Sadikot; Timothy S Blackwell
Journal:  Proc Am Thorac Soc       Date:  2005
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.